Kenya begins enrollment for Phase I vaccine trial.
D016915:AIDS Vaccines / Q000008:administration & dosage* / Q000276:immunology; D005260:Female; D015658:HIV Infections / Q000517:prevention & control*; D006801:Humans; D007630:Kenya; D018579:Patient Selection
D016915:AIDS Vaccines